Blueprint Medicines
BPMC
#2486
Rank
NZ$9.85 B
Marketcap
$154.26
Share price
-1.53%
Change (1 day)
4.73%
Change (1 year)

EPS for Blueprint Medicines (BPMC)

EPS in 2023 (TTM): -$14.88

According to Blueprint Medicines 's latest financial reports the company's current EPS (TTM) is -$16.01. In 2022 the company made an earnings per share (EPS) of -$16.29 an increase over its 2021 EPS that were of -$19.13.

EPS history for Blueprint Medicines from 2014 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$14.88-8.64%
2022-$16.29-14.85%
2021-$19.13-297.13%
2020$9.70-176.3%
2019-$12.7235.19%
2018-$9.4138.82%
2017-$6.7847.35%
2016-$4.609.25%
2015-$4.21-31.35%
2014-$6.13

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$0.12-99.24%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.47-97.06%๐Ÿ‡บ๐Ÿ‡ธ USA
-$2.21-86.18%๐Ÿ‡บ๐Ÿ‡ธ USA